Shell Asset Management CO Vertex Pharmaceuticals Inc Transaction History

Shell Asset Management CO

  • $2.11 Billion
  • Q1 2025

A detailed history of Shell Asset Management CO transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Shell Asset Management CO holds 13,372 shares of VRTX stock, worth $5.93 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
13,372
Previous 14,657 8.77%
Holding current value
$5.93 Million
Previous $5.9 Million 9.84%
% of portfolio
0.31%
Previous 0.26%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
SELL
$402.49 - $513.76 $517,199 - $660,181
-1,285 Reduced 8.77%
13,372 $6.48 Million
Q4 2024

Feb 14, 2025
BUY
$396.64 - $516.74 $31,334 - $40,822
79 Added 0.54%
14,657 $5.9 Million
Q3 2024

Nov 07, 2024
SELL
$460.0 - $505.78 $688,160 - $756,646
-1,496 Reduced 9.31%
14,578 $6.78 Million
Q1 2024

Jul 31, 2024
SELL
$407.69 - $446.08 $565,873 - $619,159
-1,388 Reduced 7.95%
16,074 $7.53 Million
Q1 2024

May 14, 2024
BUY
$407.69 - $446.08 $534,481 - $584,810
1,311 Added 8.12%
17,462 $7.3 Million
Q4 2023

Feb 14, 2024
SELL
$343.0 - $410.68 $966,231 - $1.16 Million
-2,817 Reduced 14.85%
16,151 $6.57 Million
Q3 2023

Nov 08, 2023
SELL
$338.18 - $362.46 $71,694 - $76,841
-212 Reduced 1.11%
18,968 $6.6 Million
Q2 2023

Jul 28, 2023
BUY
$314.42 - $351.91 $288,951 - $323,405
919 Added 5.03%
19,180 $6.75 Million
Q1 2023

May 15, 2023
SELL
$283.23 - $323.1 $11,612 - $13,247
-41 Reduced 0.22%
18,261 $5.75 Million
Q4 2022

Feb 07, 2023
SELL
$285.76 - $321.48 $1.58 Million - $1.78 Million
-5,523 Reduced 23.18%
18,302 $5.29 Million
Q3 2022

Nov 14, 2022
SELL
$273.83 - $305.53 $1.47 Million - $1.64 Million
-5,375 Reduced 18.41%
23,825 $6.9 Million
Q2 2022

Aug 09, 2022
SELL
$234.96 - $292.55 $897,782 - $1.12 Million
-3,821 Reduced 11.57%
29,200 $8.23 Million
Q1 2022

May 04, 2022
BUY
$221.42 - $260.97 $925,978 - $1.09 Million
4,182 Added 14.5%
33,021 $8.62 Million
Q4 2021

Feb 09, 2022
SELL
$177.01 - $223.45 $1.42 Million - $1.79 Million
-8,012 Reduced 21.74%
28,839 $6.33 Million
Q3 2021

Nov 04, 2021
SELL
$181.39 - $202.99 $3.23 Million - $3.61 Million
-17,808 Reduced 32.58%
36,851 $6.68 Million
Q2 2021

Aug 12, 2021
SELL
$187.49 - $221.1 $1.45 Million - $1.7 Million
-7,709 Reduced 12.36%
54,659 $11 Million
Q1 2021

May 10, 2021
SELL
$207.02 - $241.31 $3.09 Million - $3.6 Million
-14,921 Reduced 19.31%
62,368 $13.4 Million
Q4 2020

Feb 16, 2021
BUY
$207.01 - $276.09 $5.25 Million - $7 Million
25,367 Added 48.86%
77,289 $18.3 Million
Q3 2020

Nov 13, 2020
SELL
$255.65 - $303.1 $82,319 - $97,598
-322 Reduced 0.62%
51,922 $14.1 Million
Q2 2020

Aug 10, 2020
BUY
$225.48 - $295.8 $8.13 Million - $10.7 Million
36,049 Added 222.59%
52,244 $15.2 Million
Q1 2020

May 11, 2020
SELL
$199.77 - $247.81 $361,783 - $448,783
-1,811 Reduced 10.06%
16,195 $3.85 Million
Q4 2019

Feb 13, 2020
SELL
$166.71 - $223.91 $84,521 - $113,522
-507 Reduced 2.74%
18,006 $3.94 Million
Q3 2019

Nov 12, 2019
SELL
$166.23 - $187.09 $405,268 - $456,125
-2,438 Reduced 11.64%
18,513 $3.14 Million
Q2 2019

Aug 12, 2019
BUY
$164.61 - $190.37 $158,684 - $183,516
964 Added 4.82%
20,951 $3.84 Million
Q1 2019

May 09, 2019
BUY
$163.73 - $194.7 $215,141 - $255,835
1,314 Added 7.04%
19,987 $3.68 Million
Q4 2018

Feb 13, 2019
SELL
$151.91 - $192.21 $768,664 - $972,582
-5,060 Reduced 21.32%
18,673 $3.09 Million
Q3 2018

Nov 13, 2018
SELL
$167.73 - $192.74 $178,967 - $205,653
-1,067 Reduced 4.3%
23,733 $4.57 Million
Q2 2018

Aug 10, 2018
BUY
$145.72 - $169.96 $192,787 - $224,857
1,323 Added 5.64%
24,800 $4.22 Million
Q1 2018

May 14, 2018
SELL
$151.6 - $177.13 $182,981 - $213,795
-1,207 Reduced 4.89%
23,477 $3.83 Million
Q4 2017

Feb 09, 2018
BUY
$137.28 - $155.55 $431,333 - $488,738
3,142 Added 14.59%
24,684 $3.7 Million
Q3 2017

Oct 20, 2017
SELL
$148.13 - $162.24 $3.69 Million - $4.04 Million
-24,911 Reduced 53.63%
21,542 $3.28 Million
Q3 2017

Oct 18, 2017
BUY
$148.13 - $162.24 $6.88 Million - $7.54 Million
46,453
46,453 $5.22 Million

Others Institutions Holding VRTX

# of Institutions
1,833
Shares Held
233M
Call Options Held
1.38M
Put Options Held
1.08M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $114B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Shell Asset Management CO Portfolio

Follow Shell Asset Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email